KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice

Search results for "Phase 3 trial"

Home
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
01/08/2026, 17:50 ET
Breast Cancer Treatment, Does Adding ‘This’ Increase Survival Rates?

Breast Cancer Treatment, Does Adding ‘This’ Increase Survival Rates?

A domestic research team has announced findings that could improve the prognosis of breast cancer patients.
12/22/2025, 18:40 ET
Previous789
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 41, Mapo-daero 4da-gil, Mapo-gu, Seoul, Henkel Tower (2nd Floor, Mapo Tower)
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All Rights Reserved.Powered by 팡고링고
Languages

ENGLISH

English (US)

ASIAN

Монгол日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية